Article / 4
Article PDF Full-Issue Download View Details Source Title| Cite Article Cite Article

MLA

Rastogi, Rohit, et al. "Identification of Drug Compound Bio-Activities Through Artificial Intelligence." IJHSTM vol.3, no.1 2023: pp.1-34. http://doi.org/10.4018/IJHSTM.315800

APA

Rastogi, R., Rastogi, Y., Rathaur, S. K., & Srivastava, V. (2023). Identification of Drug Compound Bio-Activities Through Artificial Intelligence. International Journal of Health Systems and Translational Medicine (IJHSTM), 3(1), 1-34. http://doi.org/10.4018/IJHSTM.315800

Chicago

Rastogi, Rohit, et al. "Identification of Drug Compound Bio-Activities Through Artificial Intelligence," International Journal of Health Systems and Translational Medicine (IJHSTM) 3, no.1: 1-34. http://doi.org/10.4018/IJHSTM.315800

Export Reference

Mendeley
Identification of Drug Compound Bio-Activities Through Artificial Intelligence

International Journal of Health Systems and Translational Medicine (IJHSTM)

The International Journal of Health Systems and Translational Medicine (IJHSTM) provides a forum for the extensive new techniques, strategies, and technologies of new health systems and methods in the field of health informatics and computer science. The journal covers topical issues including scientific and health research which can promote and accelerate the translation of health innovation to the intelligent health application and the communication between basic and clinical scientists. The journal emphasizes the health potential and application of new biotechnologies, bioengineering, bioinformatics, medical imaging, and the basic science of local and systemic response related to the medical sciences, regulation, and health policies. The journal focuses on biomedical and health applications, smart diagnostics, personalized-medicine, translational medicine, translational research for health care, biomedical-research, and translational health medicine. The International Journal of Health Systems and Translational Medicine (IJHSTM) welcomes submissions from companies, clinicians, scientists and policy makers. This journal offers research contributions, constructive debates, and investigations on new innovations on translational medicine technologies, healthcare informatics, and applications for both the manufacturing and service industries.
View source title
Article / 4